Interrupted time series analysis for the weekly number of dependent group inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

Result of the interrupted time series analysis for the weekly number of independent group inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

Flow of case selection. by Hiroyuki Nagano (4013804)

Subjects:

Result of the interrupted time series analysis for the weekly number of inpatients with ischemic stroke between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

The result of interrupted time series analysis for weekly proportions of inpatient cases receiving intravenous thrombolysis between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

The total number, characteristics, and time-sensitive treatment approaches of inpatient cases with ischemic stroke before and after the declaration of state of emergency. by Hiroyuki Nagano (4013804)

Subjects:

The result of the interrupted time series analysis for weekly proportions of inpatient cases receiving endovascular intervention between April 1 2018 and June 27 2020. by Hiroyuki Nagano (4013804)

Subjects:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects:

Significant achievement in reduction of maternal and neonatal deaths. by Ruoyan Gai Tobe (102986)

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Subjects:

Results of a meta-analysis of the surgery risk factors: A: Number of implants: there was no significant difference in number of implants between two groups (1 vs > 1); B: Reduction: there was significant difference in reduction between two groups (reduction vs no reduction); C: Reduction method: there was significant difference in reduction method between two groups (closed vs open); D: Delayed surgery: there was no significant difference in delayed surgery between two groups (≤24h vs > 24h); E: Capsular decompression: there was no significant difference in capsular decompression between two groups (decompression vs no decompression). by Zihang Xu (4028183)

“…<p>Results of a meta-analysis of the surgery risk factors: A: Number of implants: there was no significant difference in number of implants between two groups (1 vs > 1); B: Reduction: there was significant difference in reduction between two groups (reduction vs no reduction); C: Reduction method: there was significant difference in reduction method between two groups (closed vs open); D: Delayed surgery: there was no significant difference in delayed surgery between two groups (≤24h vs > 24h); E: Capsular decompression: there was no significant difference in capsular decompression between two groups (decompression vs no decompression).…”

Brain areas with significant rCBF increase in within-group comparisons in each group. by Yutaro Mori (3125268)

Lab parameters–Significant reduction in means. by Harleen Kaur (288288)

“…Adjuvant homoeopathic medicines were given in the treatment group and SOC was given to both groups. The duration of oxygen support was compared as the primary outcome. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Subjects:

Network of energy metabolites with significantly altered abundances in <i>Ubi</i> > <i>bmm-RNAi</i> flies. by Nestor O. Nazario-Yepiz (4386478)

Nucleotide metabolism network intermediates with significantly altered abundances <i>Ubi</i> > <i>bmm-RNAi</i> flies. by Nestor O. Nazario-Yepiz (4386478)

Carbohydrate metabolism network with biochemicals with significantly altered abundances in <i>Ubi</i> > <i>bmm-RNAi</i> flies. by Nestor O. Nazario-Yepiz (4386478)

Peptide metabolism network intermediates with significantly altered abundances in <i>Ubi</i> > <i>bmm-RNAi</i> flies. by Nestor O. Nazario-Yepiz (4386478)